Hadassah

Hadassah Mourns the Loss of Aretha Franklin and Urges Greater Awareness of Diagnosis and Treatment of Pancreatic Cancer

Friday, Aug 17 2018

Aretha Franklin (Courtesy CSU Archives/Everett Collection)

Sadly, the “queen of soul” Aretha Franklin passed away yesterday at age 76, due to an advanced pancreatic neuroendocrine tumor (pancreatic NET or PNET). 

Beloved by countless fans for the transcendent, timeless, and deeply moving quality of her music, Aretha left a legacy that musicians and music lovers will cherish.  Hadassah offers its condolences to Ms. Franklin’s family and relatives on the passing of this American music icon and legend.  The PNET that took Aretha’s life is a rare cancer (~ six percent of all pancreatic tumors), which develops from the abnormal growth of endocrine (hormone-producing) cells in the pancreas.

As Dr. Simona Glasberg, head of the Neuroendocrine Tumor Unit at the Hadassah Medical Organization, explains, "One of the major issues with these tumors is their timely diagnosis, as many times they are missed. Increasing awareness within the medical community and general population of these rare tumors is extremely important, as is the timely referral to a specialized center that is experienced in treating these rare cancers."

Whereas PNETs tend to grow slower than the usual aggressive pancreatic adenocarcinoma, Dr. Glasberg says, “they always have a malignant potential to spread locally or to other organs.  Often, they are diagnosed at an advanced stage of metastatic disease. The symptoms of PNETs are usually related to the tumor-mass growth and spread (e.g., abdominal pain, weight loss, loss of appetite, jaundice, etc.). However, in about 25 percent of cases, these tumors may produce specific hormonal-hypersecretion syndromes, causing diarrhea, severe weakness, sweating, and loss of consciousness. The Neuroendocrine Tumor Unit at Hadassah, with its dedicated multidisciplinary team, is a global leader in NET treatment and research.  Recently,  the European Neuroendocrine Tumor Society (ENETS) certified Hadassah’s unit as the only center of excellence in Israel and the Middle East.  

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Jul 11 2019

Hadassah Doctors Give a Gazan Patient With an Incurable Skin Disease a “Normal Life”

Pioneering treatment by physicians at Hadassah Hospital Ein Kerem is giving a Gazan man who suffers from...

READ MORE ›
alt_text

Thursday, Jul 11 2019

Breakthrough at Hadassah Hospital in Correcting Scoliosis for Special-Needs Teen

Spine specialists at Hadassah Hospital Ein Kerem used an innovative, minimally invasive approach to correct scoliosis in a 14-year-old with Down syndrome.

READ MORE ›
alt_text

Tuesday, Jul 2 2019

The School That Helps You Forget Your Cancer

With her eyes sparkling with excitement, five-year-old Osher Tubiyan said goodbye to Hadassah's hospitalized children’s school after eight months of successfully struggling with leukemia.

READ MORE ›
alt_text

Tuesday, Jul 2 2019

Hadassah Researchers Adapt a Text-Messaging Program to Help IDF Soldiers Kick the Tobacco Habit

Researchers from Hadassah, the Hebrew University, the Israel Defense Forces Medical Corps, and the Israel Cancer Association have shown for the first time that a text-based cessation program can help soldiers stop smoking.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More